Tami Tillotson Martin Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Tami Tillotson Martin is Sr. V.P., Regulatory Affairs of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 86,933 shares of SUPN, which is worth approximately $2.79 Million. The most recent transaction as insider was on Feb 23, 2024, when has been sold 485 shares (Common Stock) at a price of $29.06 per share, resulting in proceeds of $14,094. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.9K

0% 3M change

1.98% 12M change

Total Value Held $2.79 Million

Tami Tillotson Martin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 23 2024	SELL Payment of exercise price or tax liability	$14,094 $29.06 p/Share	485 Reduced 0.55%	86,933 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	1,250 Added 1.41%	87,418 Common Stock
Feb 22 2024	SELL Payment of exercise price or tax liability	$6,873 $27.94 p/Share	246 Reduced 0.28%	86,168 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	750 Added 0.86%	86,414 Common Stock
Jan 10 2024	SELL Open market or private sale	$223,280 $27.91 p/Share	8,000 Reduced 8.54%	85,664 Common Stock
Jan 10 2024	BUY Exercise of conversion of derivative security	$73,920 $9.24 p/Share	8,000 Added 7.87%	93,664 Common Stock
Aug 30 2023	SELL Open market or private sale	$259,200 $32.0 p/Share	8,100 Reduced 8.68%	85,249 Common Stock
Aug 30 2023	BUY Exercise of conversion of derivative security	$194,319 $23.99 p/Share	8,100 Added 7.98%	93,349 Common Stock
Aug 25 2023	SELL Open market or private sale	$162,214 $31.59 p/Share	5,135 Reduced 5.68%	85,249 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	750 Added 0.82%	90,323 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	1,500 Added 1.66%	88,720 Common Stock
Aug 22 2022	SELL Open market or private sale	$179,900 $35.98 p/Share	5,000 Reduced 5.42%	87,220 Common Stock
Aug 22 2022	BUY Exercise of conversion of derivative security	$39,500 $7.9 p/Share	5,000 Added 5.14%	92,220 Common Stock
Aug 04 2022	SELL Open market or private sale	$164,900 $32.98 p/Share	5,000 Reduced 5.42%	87,220 Common Stock
Aug 04 2022	BUY Exercise of conversion of derivative security	$39,500 $7.9 p/Share	5,000 Added 5.14%	92,220 Common Stock
Apr 14 2021	SELL Open market or private sale	$99,937 $31.98 p/Share	3,125 Reduced 3.49%	86,326 Common Stock
Apr 14 2021	BUY Exercise of conversion of derivative security	$40,562 $12.98 p/Share	3,125 Added 3.38%	89,451 Common Stock
Apr 13 2021	SELL Open market or private sale	$93,687 $29.98 p/Share	3,125 Reduced 3.49%	86,326 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	$40,562 $12.98 p/Share	3,125 Added 3.38%	89,451 Common Stock

TTM

Tami Tillotson Martin

Sr. V.P., Regulatory Affairs

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Value

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN

Account